Complete Filing Data
HERON THERAPEUTICS, INC. /DE/ reported Net Income Loss of -$20.20 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean HERON THERAPEUTICS, INC. /DE/ did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$20.2M | -$13.6M | -$110.6M | -$182.0M | -$220.7M | -$227.3M | -$204.7M | -$178.8M | -$197.5M | -$173.1M | -$97.6M | -$76.4M | -$55.3M | -$23.3M | -$11.8M | -$7.3M | -$10.0M |
| Cost of Revenue * | $41.3M | $38.6M | $65.1M | $54.9M | $46.0M | $36.2M | $61.6M | $27.5M | $4.6M | $35.0K | |||||||
| Revenue * | $154.9M | $144.3M | $127.0M | $107.7M | $86.3M | $88.6M | $146.0M | $77.5M | $30.8M | $1.3M | |||||||
| Research And Development Expense | $12.4M | $16.7M | $39.1M | $82.7M | $130.8M | $174.5M | $167.4M | $140.0M | $138.6M | $103.1M | $61.2M | $54.8M | $32.5M | $15.2M | $8.2M | $7.3M | $7.8M |
| General And Administrative Expense | $54.6M | $53.4M | $65.8M | $62.2M | $40.2M | $42.2M | $37.9M | $29.3M | $25.6M | $21.4M | $18.4M | $11.0M | $21.9M | $8.7M | $3.5M | $4.0M | $3.7M |
| Operating Income Loss | -$2.5M | -$11.5M | -$110.6M | -$174.7M | -$217.8M | -$228.2M | -$210.7M | -$183.9M | -$194.6M | -$170.9M | -$96.9M | -$74.6M | -$54.5M | -$23.8M | -$11.1M | -$9.9M | -$10.2M |
| Comprehensive Income Net Of Tax | -$20.2M | -$13.6M | -$110.5M | -$182.0M | -$220.9M | -$227.1M | -$204.6M | -$178.9M | -$197.5M | -$173.1M | -$97.6M | -$76.4M | -$55.3M | ||||
| Selling And Marketing Expense | $49.1M | $47.1M | $67.6M | $82.5M | $87.2M | $63.9M | $89.8M | $64.6M | $56.6M | $47.7M | $17.3M | $8.7M | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$9.0K | $32.0K | -$13.0K | -$263.0K | $172.0K | $172.0K | -$77.0K | $7.0K | $23.0K | -$40.0K | |||||||
| Other Nonoperating Income Expense | $1.3M | $430.0K | $560.0K | -$6.5M | -$878.0K | -$847.0K | $158.0K | $1.8M | -$38.0K | -$9.0K | $118.0K | -$919.0K | $2.0K | $6.0K | $240.0K | ||
| Operating Expenses | $261.4M | $225.3M | $172.2M | $96.9M | $74.6M | $54.5M | $23.8M | $11.7M | $11.2M | $11.5M | |||||||
| Interest Expense | $3.9M | $2.5M | $2.4M | $1.9M | $1.5M | $2.7M | $3.9M | $2.7M | $958.0K | $887.0K | $828.0K | $605.0K | |||||
| Nonoperating Income Expense | -$17.7M | -$2.1M | $56.0K | -$7.4M | -$2.9M | $885.0K | $5.9M | $5.1M | -$2.9M | -$2.2M | -$666.0K | -$1.8M | -$826.0K | -$599.0K | |||
| Income Loss From Continuing Operations | -$76.4M | -$55.3M | -$24.4M | -$11.4M | -$7.2M | -$10.1M | |||||||||||
| Asset Impairment Charges | $617.0K | $209.0K | $478.0K | $847.0K | $107.0K | $72.0K | $0.00 | $0.00 | $905.0K | $0.00 | |||||||
| Income Loss From Continuing Operations Per Basic And Diluted Share | -$2.87 | -$3.42 | -$2.00 | -$1.90 | -$0.18 | -$0.31 | |||||||||||
| Interest Income Expense Nonoperating Net | -$826.0K | -$599.0K | -$373.0K | -$2.0K | $29.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$17.5M | -$2.4M | $2.6M | -$4.8M | -$9.2M | -$3.2M | -$25.0M | -$42.1M | -$32.8M | -$41.9M | -$56.4M | -$63.9M | -$52.4M | -$61.0M | -$52.6M | -$62.3M | -$58.2M | -$55.2M | -$51.6M | -$57.9M | -$33.6M | -$50.2M | -$63.0M | -$49.6M | -$38.3M | -$38.7M | -$52.3M | -$62.5M | -$41.9M | -$42.8M | -$50.3M | -$48.0M | -$48.5M | -$43.2M | -$33.4M | -$31.2M | -$22.7M | -$23.1M | -$20.6M | -$20.6M | -$19.2M | -$19.0M | -$17.5M | -$14.0M | -$12.9M | -$15.4M | -$13.0M | -$7.7M | -$6.1M | -$4.6M | -$13.0M | -$4.3M | -$4.2M | -$1.9M | -$1.4M | -$1.7M | -$3.6M |
| Cost of Revenue * | $11.9M | $9.9M | $8.5M | $9.5M | $10.5M | $8.4M | $18.2M | $20.2M | $16.9M | $14.7M | $16.2M | $11.4M | $11.4M | $14.5M | $9.2M | $9.4M | $7.2M | $9.0M | $10.6M | $15.9M | $17.2M | $13.6M | $15.0M | $11.6M | $7.6M | $5.2M | $3.1M | $1.3M | $1.1M | $1.0M | $1.2M | $35.0K | |||||||||||||||||||||||||
| Revenue * | $38.2M | $37.2M | $38.9M | $32.8M | $36.0M | $34.7M | $31.4M | $31.8M | $29.6M | $26.6M | $27.6M | $23.5M | $23.2M | $22.4M | $20.0M | $20.6M | $20.0M | $22.7M | $25.4M | $35.1M | $42.6M | $36.7M | $31.6M | $28.8M | $19.8M | $17.3M | $11.6M | $10.1M | $8.6M | $8.5M | $3.6M | $1.3M | |||||||||||||||||||||||||
| Research And Development Expense | $3.5M | $2.9M | $2.3M | $4.5M | $4.4M | $4.6M | $9.3M | $13.2M | $8.8M | $25.5M | $28.8M | $42.1M | $28.6M | $35.2M | $38.1M | $44.5M | $49.2M | $44.0M | $36.9M | $48.3M | $34.7M | $41.4M | $43.0M | $39.9M | $30.4M | $30.2M | $39.6M | $47.8M | $28.8M | $28.6M | $33.4M | $29.5M | $30.2M | $27.3M | $16.1M | $16.3M | $14.2M | $16.2M | $14.5M | $14.2M | $14.7M | $14.3M | $11.6M | $8.5M | $6.2M | $10.7M | $7.1M | $3.6M | $3.1M | $7.1M | $2.9M | $1.3M | $1.1M | $1.5M | $1.9M | ||
| General And Administrative Expense | $14.0M | $14.5M | $12.7M | $12.4M | $13.9M | $15.0M | $15.9M | $19.6M | $15.8M | $9.8M | $9.2M | $9.5M | $9.8M | $10.9M | $9.6M | $12.5M | $9.5M | $9.8M | $10.4M | $9.9M | $8.6M | $9.8M | $9.6M | $8.7M | $7.3M | $6.2M | $7.0M | $6.2M | $6.5M | $6.2M | $6.7M | $5.9M | $5.3M | $4.8M | $5.4M | $6.6M | $4.1M | $4.1M | $3.6M | $5.3M | $4.2M | $4.5M | $5.7M | $5.3M | $6.5M | $4.5M | $5.6M | $2.4M | $1.3M | $5.7M | $1.2M | $509.0K | $569.0K | $445.0K | $2.3M | ||
| Operating Income Loss | -$4.1M | -$1.6M | $3.2M | -$4.5M | -$6.4M | -$4.8M | -$24.9M | -$42.4M | -$33.1M | -$41.9M | -$49.5M | -$62.9M | -$51.7M | -$60.5M | -$52.1M | -$61.3M | -$58.4M | -$55.7M | -$52.7M | -$59.4M | -$34.9M | -$51.8M | -$64.7M | -$51.3M | -$41.8M | -$38.9M | -$52.0M | -$41.3M | -$42.1M | -$49.3M | -$47.7M | -$43.1M | -$33.3M | -$22.5M | -$23.0M | -$20.4M | -$19.0M | -$18.8M | -$17.3M | -$12.7M | -$15.2M | -$12.8M | -$6.1M | -$4.4M | -$4.8M | -$4.1M | -$1.5M | -$1.3M | -$1.6M | -$3.7M | |||||||
| Comprehensive Income Net Of Tax | -$17.5M | -$2.4M | $2.6M | -$4.8M | -$9.2M | -$3.2M | -$25.0M | -$42.1M | -$32.7M | -$42.0M | -$56.4M | -$63.9M | -$52.5M | -$61.1M | -$52.8M | -$58.6M | -$54.9M | -$51.0M | -$33.6M | -$50.1M | -$62.9M | -$38.4M | -$38.7M | -$52.3M | -$41.9M | -$42.8M | -$50.3M | -$48.5M | -$43.2M | -$33.4M | -$22.7M | -$23.1M | -$20.6M | ||||||||||||||||||||||||
| Selling And Marketing Expense | $12.9M | $11.6M | $12.3M | $11.0M | $13.6M | $11.4M | $13.0M | $21.2M | $21.2M | $18.4M | $22.9M | $23.4M | $25.2M | $22.3M | $15.2M | $15.6M | $12.5M | $15.6M | $20.2M | $20.4M | $17.0M | $23.6M | $28.7M | $20.0M | $16.3M | $14.5M | $13.8M | $16.7M | $13.5M | $14.8M | $11.6M | $12.7M | $12.2M | $11.0M | $11.9M | $8.2M | $4.1M | $2.8M | $2.3M | ||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.0K | -$2.0K | -$12.0K | $48.0K | -$2.0K | -$19.0K | $5.0K | -$15.0K | $28.0K | -$46.0K | -$3.0K | -$2.0K | -$45.0K | -$80.0K | -$136.0K | -$413.0K | $245.0K | $623.0K | -$45.0K | $112.0K | $123.0K | -$17.0K | $17.0K | -$32.0K | $6.0K | $24.0K | -$13.0K | -$16.0K | -$2.0K | $41.0K | |||||||||||||||||||||||||||
| Other Nonoperating Income Expense | -$2.1M | -$744.0K | -$519.0K | -$390.0K | -$2.8M | $1.6M | -$79.0K | $344.0K | $295.0K | -$26.0K | -$6.9M | -$965.0K | -$700.0K | -$546.0K | -$500.0K | $156.0K | $559.0K | $1.2M | $1.3M | $1.6M | $1.7M | $3.4M | $183.0K | -$275.0K | -$600.0K | -$552.0K | -$744.0K | -$1.0M | -$1.2M | -$775.0K | -$160.0K | -$133.0K | -$181.0K | $118.0K | -$905.0K | -$17.0K | -$220.0K | ||||||||||||||||||||
| Operating Expenses | $96.3M | $61.6M | $56.1M | $63.6M | $49.9M | $50.6M | $52.9M | $47.7M | $43.1M | $33.3M | $22.5M | $23.0M | $20.4M | $19.0M | $18.8M | $17.3M | $13.8M | $12.7M | $15.2M | $12.8M | $8.6M | $6.1M | $4.4M | $4.8M | $4.1M | $4.1M | $1.8M | $1.7M | $2.0M | $4.2M | |||||||||||||||||||||||||||
| Interest Expense | $1.0M | $1.3M | $886.0K | $257.0K | $133.0K | $247.0K | $242.0K | $237.0K | $232.0K | $227.0K | $224.0K | $220.0K | $216.0K | $212.0K | $209.0K | $205.0K | $201.0K | $202.0K | |||||||||||||||||||||||||||||||||||||||
| Nonoperating Income Expense | -$985.0K | $156.0K | $559.0K | $1.2M | $1.4M | $1.3M | $1.6M | $1.7M | $1.8M | $3.4M | $183.0K | -$275.0K | -$600.0K | -$552.0K | -$744.0K | -$1.0M | -$210.0K | -$216.0K | |||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations | -$19.5M | -$19.0M | -$18.8M | -$17.3M | -$13.8M | -$12.7M | -$15.2M | -$13.0M | -$8.8M | -$6.2M | -$4.5M | -$12.8M | -$4.2M | -$4.2M | -$1.8M | -$1.3M | -$1.6M | -$3.7M | |||||||||||||||||||||||||||||||||||||||
| Asset Impairment Charges | $170.0K | $154.0K | $47.0K | $80.0K | $27.0K | $27.0K | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic And Diluted Share | -$0.04 | -$0.05 | -$0.04 | -$0.58 | -$0.46 | -$0.45 | -$0.48 | -$0.02 | -$0.02 | -$0.05 | -$0.03 | -$0.04 | -$0.09 | ||||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense Nonoperating Net | -$552.0K | -$744.0K | -$775.0K | -$160.0K | -$212.0K | -$209.0K | -$204.0K | -$201.0K | -$197.0K | -$195.0K | -$146.0K | -$61.0K | -$62.0K | -$263.0K | -$1.0K | -$1.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $14.3M | -$33.7M | -$34.0M | $13.6M | $77.6M | $236.5M | $403.8M | $370.2M | $131.1M | -$21.3M | $118.1M | $63.1M | $68.9M | $51.8M | $15.8M | $1.3M | $6.8M | |
| Cash And Cash Equivalents At Carrying Value | $28.6M | $25.8M | $28.7M | $15.4M | $90.5M | $105.1M | $71.9M | $31.8M | $13.4M | $75.2M | $72.7M | $72.3M | $53.5M | $18.0M | $2.1M | $7.6M | $10.0M | |
| Amortization Of Debt Discount Premium | $744.0K | $751.0K | $133.0K | $785.0K | $1.4M | $1.1M | $890.0K | $773.0K | $689.0K | $624.0K | $573.0K | $533.0K | $389.0K | $103.0K | ||||
| Retained Earnings Accumulated Deficit | -$1.94B | -$1.92B | -$1.91B | -$1.80B | -$1.61B | -$1.39B | -$1.17B | -$960.7M | -$783.5M | -$586.0M | -$412.8M | -$315.2M | -$238.9M | -$183.6M | -$160.2M | -$148.4M | ||
| Property Plant And Equipment Net | $12.4M | $14.9M | $20.2M | $22.2M | $23.7M | $22.7M | $19.6M | $14.7M | $6.0M | $5.1M | $3.0M | $2.8M | $2.9M | $1.8M | $1.1M | $357.0K | ||
| Prepaid Expense And Other Assets Current | $9.1M | $17.7M | $6.1M | $14.0M | $13.0M | $22.0M | $23.2M | $11.2M | $3.7M | $3.7M | $3.6M | $1.1M | $638.0K | $584.0K | $266.0K | $282.0K | ||
| Liabilities Current | $96.1M | $91.5M | $79.7M | $82.4M | $71.1M | $102.5M | $96.7M | $92.0M | $103.2M | $38.7M | $19.7M | $13.6M | $7.0M | $4.2M | $3.7M | $1.6M | ||
| Liabilities And Stockholders Equity | $255.9M | $233.1M | $222.5M | $251.0M | $305.7M | $353.6M | $512.8M | $462.2M | $234.3M | $67.5M | $137.8M | $76.7M | $75.9M | $56.0M | $19.4M | $2.9M | ||
| Common Stock Value | $1.9M | $1.5M | $1.5M | $1.2M | $1.0M | $913.0K | $903.0K | $782.0K | $646.0K | $394.0K | $361.0K | $292.0K | $237.0K | $152.0K | $2.0M | $401.0K | ||
| Assets Current | $238.1M | $209.0M | $188.8M | $205.4M | $254.4M | $314.2M | $479.1M | $447.2M | $228.1M | $62.1M | $134.8M | $73.7M | $72.9M | $54.1M | $18.2M | $2.5M | ||
| Assets | $255.9M | $233.1M | $222.5M | $251.0M | $305.7M | $353.6M | $512.8M | $462.2M | $234.3M | $67.5M | $137.8M | $76.7M | $75.9M | $56.0M | $19.4M | $2.9M | ||
| Accounts Payable Current | $9.0M | $11.7M | $3.2M | $3.2M | $3.8M | $525.0K | $2.8M | $16.9M | $18.8M | $6.8M | $3.3M | $2.5M | $1.3M | $1.9M | $1.0M | $159.0K | ||
| Other Assets Noncurrent | $5.4M | $6.5M | $8.1M | $15.7M | $17.7M | $346.0K | $346.0K | $254.0K | $263.0K | $263.0K | $45.0K | $130.0K | $130.0K | $130.0K | $130.0K | $53.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $28.6M | $25.8M | $28.7M | $15.4M | $90.5M | $105.1M | $71.9M | $31.8M | $144.6M | $13.4M | ||||||||
| Other Accrued Liabilities Current | $51.2M | $41.8M | $41.9M | $38.6M | $25.9M | $28.4M | $36.5M | $32.7M | $17.2M | $6.3M | $4.2M | $2.9M | $364.0K | |||||
| Employee Related Liabilities Current | $9.3M | $9.6M | $9.2M | $13.4M | $15.3M | $13.6M | $15.2M | $13.4M | $8.9M | $8.4M | $4.8M | $2.7M | $2.6M | |||||
| Accrued Clinical Liabilities | $26.6M | $25.4M | $22.3M | $24.5M | $23.7M | $50.0M | $34.6M | $24.5M | $26.9M | $13.2M | $5.2M | $3.8M | $1.8M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $4.0K | $13.0K | $13.0K | -$19.0K | -$6.0K | $257.0K | $85.0K | -$87.0K | -$10.0K | -$17.0K | -$40.0K | |||||||
| Convertible Notes Payable Related Parties Current | $7.1M | $5.6M | $4.6M | $3.7M | $2.9M | $2.2M | $1.6M | $1.0M | $492.0K | $103.0K | ||||||||
| Inventory Net | $92.7M | $53.2M | $42.1M | $54.6M | $48.4M | $41.9M | $25.0M | $39.0M | $10.1M | $5.3M | ||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $739.0K | $2.1M | $1.7M | $736.0K | -$332.0K | -$125.0K | $3.7M | $3.4M | $278.0K | -$274.0K | -$89.0K | |||||||
| Liabilities | $241.5M | $266.8M | $256.5M | $237.4M | $228.1M | $117.1M | $108.9M | $92.0M | $103.2M | $88.7M | $19.7M | $1.6M | ||||||
| Accounts Receivable Net Current | $89.6M | $78.9M | $60.1M | $52.0M | $35.5M | $41.9M | $39.9M | $64.7M | $41.9M | $2.0M | $110.0K | |||||||
| Cash And Cash Equivalents Period Increase Decrease | -$112.7M | $131.2M | -$61.8M | $2.5M | $388.0K | $18.8M | $35.5M | $15.9M | -$5.5M | -$2.4M | ||||||||
| Gain Loss On Sale Of Property Plant Equipment | $27.0K | -$10.0K | -$74.0K | -$822.0K | -$62.0K | -$29.0K | -$39.0K | -$9.0K | $118.0K | -$17.0K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.8M | -$2.9M | $13.3M | -$75.2M | -$14.6M | $33.2M | $40.1M | -$112.7M | $131.2M | |||||||||
| Operating Lease Right Of Use Asset | $0.00 | $2.8M | $5.4M | $7.6M | $9.8M | $16.3M | $13.8M | $13.7M | ||||||||||
| Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature | $230.0K | $440.0K | $416.0K | $392.0K | $369.0K | $348.0K | ||||||||||||
| Operating Lease Liability Current | $0.00 | $3.0M | $3.1M | $2.7M | $2.4M | $3.0M | $1.9M | |||||||||||
| Available For Sale Securities Debt Securities Current | $18.0M | $33.5M | $51.7M | $69.5M | $67.0M | $103.4M | $319.1M | $300.5M | ||||||||||
| Operating Lease Liability Noncurrent | $2.8M | $5.5M | $8.0M | $14.6M | $12.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $14.9M | -$27.3M | -$28.5M | -$40.0M | -$37.9M | -$33.8M | -$27.8M | -$39.3M | -$11.4M | $22.5M | -$21.7M | $24.0M | $118.8M | $160.1M | $196.2M | $277.1M | $324.1M | $365.5M | $285.4M | $305.4M | $331.8M | $406.8M | $431.9M | $92.2M | $40.1M | $69.1M | $102.2M | $17.9M | $57.8M | $92.7M | $141.7M | $159.9M | $48.0M | $81.0M | $97.8M | $55.4M | $20.9M | $28.5M | $41.4M | $57.5M | $11.1M | $11.6M | $19.2M | $18.9M | |||||
| Cash And Cash Equivalents At Carrying Value | $43.1M | $16.5M | $19.3M | $25.7M | $18.4M | $20.5M | $34.9M | $13.5M | $27.1M | $50.4M | $48.6M | $56.9M | $159.6M | $191.2M | $59.7M | $95.1M | $80.7M | $103.3M | $60.1M | $53.0M | $23.5M | $53.9M | $258.9M | $46.6M | $144.6M | $65.5M | $30.3M | $83.5M | $45.6M | $61.9M | $68.0M | $153.0M | $171.5M | $55.6M | $86.2M | $105.0M | $57.5M | $22.6M | $34.8M | $45.7M | $60.0M | $12.4M | $13.4M | $21.0M | $21.3M | $1.1M | $3.0M | $5.7M | |
| Amortization Of Debt Discount Premium | $158.0K | $88.0K | $502.0K | $310.0K | $247.0K | $210.0K | $185.0K | $200.0K | $170.0K | $200.0K | $200.0K | $154.0K | $151.0K | $145.0K | $142.0K | $139.0K | $135.0K | $132.0K | $130.0K | $125.0K | $96.0K | $40.0K | |||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.94B | -$1.92B | -$1.92B | -$1.92B | -$1.92B | -$1.91B | -$1.90B | -$1.87B | -$1.83B | -$1.78B | -$1.73B | -$1.68B | -$1.56B | -$1.51B | -$1.45B | -$1.33B | -$1.27B | -$1.22B | -$1.11B | -$1.07B | -$1.02B | -$911.2M | -$872.8M | -$834.1M | -$721.0M | -$679.1M | -$636.3M | -$538.0M | -$489.5M | -$446.3M | -$381.6M | -$358.9M | -$335.8M | -$294.6M | -$275.4M | -$256.4M | -$224.8M | -$212.0M | -$196.5M | -$175.9M | -$169.7M | -$165.2M | -$156.0M | -$151.8M | |||||
| Property Plant And Equipment Net | $13.0M | $13.7M | $14.5M | $15.4M | $15.9M | $19.3M | $20.8M | $20.9M | $21.5M | $22.6M | $23.5M | $23.9M | $22.8M | $22.2M | $22.7M | $21.7M | $21.9M | $21.9M | $16.3M | $17.9M | $16.3M | $10.6M | $7.5M | $6.5M | $5.3M | $5.8M | $5.7M | $4.7M | $4.5M | $3.6M | $3.0M | $2.9M | $3.0M | $2.9M | $3.0M | $2.9M | $2.9M | $2.7M | $2.7M | $1.2M | $1.1M | $1.1M | $346.0K | $263.0K | |||||
| Prepaid Expense And Other Assets Current | $22.8M | $17.4M | $26.5M | $11.3M | $7.2M | $6.6M | $10.8M | $10.7M | $14.6M | $7.6M | $9.1M | $13.1M | $27.6M | $23.7M | $24.7M | $16.4M | $13.1M | $12.4M | $16.7M | $8.7M | $11.5M | $10.2M | $6.6M | $5.5M | $4.6M | $3.7M | $3.4M | $3.1M | $3.2M | $5.1M | $2.0M | $1.9M | $945.0K | $3.0M | $518.0K | $2.3M | $763.0K | $360.0K | $427.0K | $355.0K | $557.0K | $306.0K | $301.0K | $499.0K | |||||
| Liabilities Current | $89.7M | $258.6M | $88.6M | $85.5M | $80.3M | $75.4M | $79.7M | $86.7M | $77.9M | $93.9M | $109.5M | $93.0M | $72.3M | $82.1M | $100.9M | $97.6M | $92.7M | $96.8M | $96.7M | $95.1M | $92.3M | $64.1M | $78.7M | $91.2M | $53.1M | $48.3M | $37.4M | $30.9M | $27.9M | $19.2M | $16.5M | $16.6M | $11.6M | $11.3M | $10.8M | $7.4M | $5.5M | $9.6M | $7.6M | $4.2M | $3.1M | $3.4M | $2.5M | $3.2M | |||||
| Liabilities And Stockholders Equity | $249.0M | $232.1M | $235.8M | $220.8M | $218.1M | $217.9M | $229.2M | $201.2M | $220.9M | $272.0M | $244.0M | $273.7M | $352.4M | $404.3M | $310.9M | $390.0M | $432.7M | $478.9M | $393.0M | $411.7M | $435.8M | $470.9M | $510.6M | $183.4M | $118.2M | $142.4M | $189.6M | $98.8M | $85.7M | $111.8M | $158.2M | $176.5M | $59.6M | $92.3M | $108.6M | $62.8M | $26.4M | $38.1M | $49.0M | $61.8M | $14.2M | $15.0M | $21.8M | $22.1M | |||||
| Common Stock Value | $1.8M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.4M | $1.2M | $1.2M | $1.2M | $1.0M | $1.0M | $1.0M | $1.0M | $914.0K | $909.0K | $908.0K | $906.0K | $800.0K | $798.0K | $789.0K | $780.0K | $775.0K | $650.0K | $546.0K | $539.0K | $537.0K | $391.0K | $390.0K | $363.0K | $359.0K | $356.0K | $296.0K | $292.0K | $289.0K | $239.0K | $3.1M | $3.1M | $3.1M | $3.0M | $2.0M | $2.0M | $2.0M | $401.0K | |||||
| Assets Current | $229.4M | $210.9M | $212.8M | $195.2M | $191.2M | $185.9M | $194.0M | $165.3M | $178.2M | $223.8M | $194.2M | $222.6M | $315.1M | $366.8M | $272.3M | $351.0M | $392.9M | $438.4M | $364.1M | $380.8M | $406.2M | $460.1M | $502.6M | $176.6M | $112.6M | $136.4M | $183.6M | $94.0M | $81.1M | $108.2M | $155.0M | $173.4M | $56.5M | $89.2M | $105.5M | $59.7M | $23.4M | $35.2M | $46.1M | $60.4M | $13.0M | $13.8M | $21.3M | $21.8M | |||||
| Assets | $249.0M | $232.1M | $235.8M | $220.8M | $218.1M | $217.9M | $229.2M | $201.2M | $220.9M | $272.0M | $244.0M | $273.7M | $352.4M | $404.3M | $310.9M | $390.0M | $432.7M | $478.9M | $393.0M | $411.7M | $435.8M | $470.9M | $510.6M | $183.4M | $118.2M | $142.4M | $189.6M | $98.8M | $85.7M | $111.8M | $158.2M | $176.5M | $59.6M | $92.3M | $108.6M | $62.8M | $26.4M | $38.1M | $49.0M | $61.8M | $14.2M | $15.0M | $21.8M | $22.1M | |||||
| Accounts Payable Current | $12.0M | $12.0M | $12.3M | $10.2M | $10.2M | $837.0K | $1.9M | $2.0M | $4.1M | $6.5M | $13.8M | $8.2M | $5.9M | $11.2M | $1.7M | $12.1M | $18.5M | $11.6M | $1.6M | $8.0M | $10.8M | $9.6M | $5.0M | $11.5M | $5.3M | $6.3M | $4.5M | $6.1M | $8.7M | $6.9M | $2.7M | $3.0M | $2.4M | $1.5M | $1.8M | $3.6M | $2.3M | $5.4M | $3.8M | $1.8M | $605.0K | $890.0K | $433.0K | $289.0K | |||||
| Other Assets Noncurrent | $5.9M | $6.1M | $6.3M | $6.7M | $6.9M | $7.9M | $8.4M | $8.6M | $14.1M | $17.3M | $17.5M | $18.0M | $346.0K | $346.0K | $346.0K | $346.0K | $346.0K | $346.0K | $254.0K | $254.0K | $254.0K | $253.0K | $427.0K | $316.0K | $263.0K | $263.0K | $263.0K | $130.0K | $130.0K | $174.0K | $130.0K | $130.0K | $130.0K | $130.0K | $130.0K | $153.0K | $148.0K | $130.0K | $130.0K | $130.0K | $130.0K | $130.0K | $28.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $43.1M | $16.5M | $19.3M | $25.7M | $18.4M | $20.5M | $34.9M | $13.5M | $27.1M | $50.4M | $48.6M | $56.9M | $159.6M | $191.2M | $59.7M | $95.1M | $80.7M | $103.3M | $60.1M | $53.0M | $23.5M | $53.9M | |||||||||||||||||||||||||||
| Other Accrued Liabilities Current | $48.5M | $46.2M | $47.4M | $40.7M | $42.3M | $43.8M | $39.8M | $52.4M | $40.3M | $32.7M | $33.2M | $32.8M | $30.0M | $30.2M | $24.7M | $22.0M | $23.7M | $32.4M | $51.8M | $45.9M | $44.4M | $27.4M | $19.7M | $20.6M | $15.4M | $12.2M | $7.2M | $3.6M | $2.5M | $3.2M | $3.1M | $3.1M | $2.3M | $1.2M | $2.2M | ||||||||||||||
| Employee Related Liabilities Current | $8.7M | $6.5M | $6.5M | $8.5M | $7.1M | $7.6M | $10.4M | $9.9M | $9.5M | $14.7M | $16.3M | $12.2M | $16.0M | $13.7M | $9.6M | $13.2M | $11.2M | $8.8M | $10.1M | $9.0M | $6.6M | $8.5M | $6.9M | $5.2M | $7.9M | $7.3M | $6.1M | $8.6M | $4.7M | $3.0M | $3.4M | $2.3M | $1.7M | $2.6M | $1.8M | ||||||||||||||
| Accrued Clinical Liabilities | $19.7M | $17.1M | $20.1M | $22.9M | $17.6M | $19.9M | $24.7M | $19.9M | $21.3M | $37.3M | $43.7M | $37.3M | $17.2M | $23.9M | $54.2M | $40.7M | $30.2M | $35.3M | $26.1M | $25.4M | $23.6M | $14.3M | $18.0M | $24.9M | $15.5M | $14.4M | $11.2M | $9.8M | $9.5M | $3.7M | $5.2M | $6.3M | $3.5M | $4.5M | $3.7M | ||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | -$1.0K | $1.0K | $40.0K | -$8.0K | -$6.0K | -$1.0K | -$6.0K | $9.0K | -$57.0K | -$11.0K | -$8.0K | -$4.0K | $41.0K | $121.0K | $540.0K | $953.0K | $708.0K | $103.0K | $148.0K | $36.0K | -$42.0K | -$25.0K | -$42.0K | -$6.0K | -$30.0K | -$17.0K | -$1.0K | $1.0K | ||||||||||||||||||||
| Convertible Notes Payable Related Parties Current | $7.6M | $6.6M | $6.3M | $5.9M | $5.4M | $5.1M | $4.8M | $4.3M | $4.1M | $3.9M | $3.5M | $3.3M | $3.1M | $2.7M | $2.6M | $2.4M | $2.1M | $1.9M | $1.7M | $1.5M | $1.3M | $1.2M | $888.0K | $754.0K | $622.0K | $365.0K | $239.0K | $143.0K | |||||||||||||||||||||
| Inventory Net | $70.0M | $73.0M | $56.9M | $46.0M | $42.9M | $42.5M | $42.0M | $44.6M | $52.1M | $52.2M | $61.3M | $56.5M | $41.5M | $42.8M | $42.6M | $42.7M | $41.4M | $34.8M | $24.2M | $29.3M | $31.4M | $31.4M | $27.2M | $19.4M | $5.2M | $4.8M | $4.6M | $2.0M | $3.3M | $2.7M | |||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $281.0K | $638.0K | $474.0K | -$104.0K | -$48.0K | $117.0K | $1.4M | $211.0K | $13.0K | ||||||||||||||||||||||||||||||||||||||||
| Liabilities | $234.1M | $259.3M | $264.2M | $260.8M | $256.1M | $251.7M | $257.0M | $240.5M | $232.3M | $249.5M | $265.7M | $249.8M | $233.5M | $244.1M | $114.7M | $112.9M | $108.7M | $113.5M | $107.5M | $106.3M | $104.0M | $78.1M | $73.3M | $87.4M | $80.9M | $3.4M | $3.7M | $2.6M | $3.2M | ||||||||||||||||||||
| Accounts Receivable Net Current | $81.0M | $79.9M | $78.7M | $67.0M | $73.7M | $65.3M | $63.8M | $76.7M | $51.4M | $42.2M | $40.3M | $41.1M | $43.1M | $42.6M | $38.5M | $33.7M | $37.5M | $34.8M | $67.0M | $66.8M | $74.0M | $53.6M | $45.9M | $37.7M | $28.9M | $18.6M | $10.3M | ||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$8.4M | -$98.0M | $70.1M | -$7.2M | -$17.1M | -$14.8M | -$7.8M | -$4.5M | -$1.0M | ||||||||||||||||||||||||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $34.0K | -$96.0K | -$52.0K | -$5.0K | |||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$6.5M | -$8.2M | $11.7M | -$33.6M | -$45.4M | $31.4M | -$8.4M | ||||||||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $708.0K | $1.4M | $2.1M | $3.5M | $4.1M | $4.8M | $6.1M | $6.5M | $7.1M | $8.2M | $8.8M | $9.3M | $14.2M | $14.9M | $15.6M | $16.9M | $17.6M | $18.2M | $12.2M | $12.7M | $13.1M | ||||||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature | $116.0K | $114.0K | $111.0K | $109.0K | $108.0K | $105.0K | $103.0K | $102.0K | $99.0K | $97.0K | $96.0K | ||||||||||||||||||||||||||||||||||||||
| Operating Lease Liability Current | $780.0K | $1.5M | $2.3M | $3.2M | $3.2M | $3.1M | $3.0M | $2.6M | $2.8M | $2.6M | $2.5M | $2.5M | $3.3M | $3.2M | $3.1M | $2.9M | $2.8M | $2.8M | $1.7M | $1.7M | $2.0M | ||||||||||||||||||||||||||||
| Available For Sale Securities Debt Securities Current | $12.4M | $24.1M | $31.4M | $45.1M | $49.0M | $51.1M | $42.6M | $19.8M | $32.9M | $71.3M | $34.9M | $55.0M | $43.3M | $66.5M | $106.7M | $163.0M | $220.1M | $253.1M | $196.2M | ||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $522.0K | $1.3M | $2.0M | $3.5M | $4.2M | $4.8M | $6.2M | $6.8M | $7.4M | $12.2M | $13.0M | $13.8M | $15.3M | $16.0M | $16.7M | $10.8M | $11.3M | $11.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $14.4M | $940.0K | $54.1M | $75.1M | $156.0M | $9.1M | $186.4M | $357.6M | $293.7M | $57.5M | $138.0M | $62.1M | $61.2M | $53.5M | $24.1M | $77.0K | $8.0M |
| Investing Cash Flow * | $16.0M | $18.7M | $18.0M | -$3.3M | $32.7M | $209.0M | -$21.8M | -$278.6M | $7.7M | $14.9M | -$57.0M | -$1.4M | -$1.7M | -$972.0K | -$513.0K | -$78.0K | $612.0K |
| Operating Cash Flow * | -$27.6M | -$22.5M | -$58.8M | -$146.9M | -$203.4M | -$184.8M | -$124.6M | -$191.8M | -$170.3M | -$134.1M | -$78.5M | -$60.3M | -$40.8M | -$17.0M | -$7.7M | -$5.5M | -$11.0M |
| Share Based Compensation | $10.3M | $13.0M | $32.9M | $43.0M | $46.9M | $50.2M | $51.4M | $33.4M | $30.5M | $26.0M | $14.4M | $8.1M | $10.9M | $5.7M | $1.9M | $1.7M | $1.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$878.0K | $9.9M | -$15.4M | -$1.0M | $8.4M | -$1.3M | $12.1M | $7.5M | -$3.0K | $338.0K | $2.4M | $419.0K | $54.0K | $318.0K | -$16.0K | $267.0K | -$303.0K |
| Increase Decrease In Accounts Payable | -$2.7M | $8.5M | $15.0K | -$578.0K | $3.3M | -$2.2M | -$14.1M | -$1.9M | $12.0M | $3.5M | $751.0K | $1.3M | -$426.0K | $984.0K | $467.0K | -$3.0K | -$182.0K |
| Payments To Acquire Property Plant And Equipment | $317.0K | $1.7M | $1.5M | $1.8M | $3.0M | $6.8M | $7.2M | $9.2M | $2.6M | $3.1M | $1.1M | $1.4M | $1.7M | $972.0K | $513.0K | $78.0K | $2.0K |
| Increase Decrease In Employee Related Liabilities | -$284.0K | $330.0K | -$4.2M | -$1.8M | $1.7M | -$1.7M | $1.9M | $4.5M | $446.0K | $3.6M | $2.1M | $165.0K | $2.2M | -$149.0K | |||
| Increase Decrease In Clinical Liabilities | $1.4M | $3.2M | -$2.2M | $752.0K | -$26.2M | $15.3M | $10.1M | -$3.6M | $13.7M | $8.0M | $1.4M | $2.0M | $1.1M | $92.0K | |||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 853.0K | 637.0K | 904.0K | 1.4M | 2.1M | 2.3M | 2.1M | 1.2M | 989.0K | 771.0K | 257.0K | 91.0K | 34.0K | 22.0K | 15.0K | 30.0K | 42.0K |
| Increase Decrease In Accounts Receivable | $10.7M | $18.7M | $8.1M | $16.6M | -$6.4M | $2.0M | -$24.8M | $22.8M | $39.9M | $2.0M | -$110.0K | $61.0K | -$139.0K | ||||
| Increase Decrease In Other Accrued Liabilities | $10.6M | $99.0K | $3.3M | $12.9M | -$5.3M | -$6.9M | $4.6M | $14.9M | $11.5M | $2.5M | $1.6M | $2.9M | -$36.0K | $494.0K | |||
| Increase Decrease In Inventories | $31.1M | $11.1M | -$12.5M | $6.2M | $6.5M | $16.9M | -$14.1M | $29.1M | $4.8M | $5.3M | |||||||
| Depreciation Depletion And Amortization | $2.3M | $2.5M | $2.9M | $2.9M | $3.0M | $2.8M | $2.0M | $1.5M | $1.5M | $1.1M | $734.0K | ||||||
| Proceeds From Stock Options Exercised | $6.8M | $22.2M | $18.3M | $11.5M | $6.7M | $9.5M | $3.1M | $2.8M | $0.00 | $0.00 | $47.0K | $20.0K | |||||
| Stock Issued During Period Value Share Based Compensation | $160.0K | $303.0K | -$903.0K | -$1.5M | $4.9M | $6.8M | $22.2M | ||||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $67.0M | $123.5M | $107.2M | $144.0M | $164.9M | $349.8M | $462.4M | $227.7M | $131.8M | $61.3M | |||||||
| Payments To Acquire Available For Sale Securities Debt | $50.8M | $103.1M | $87.7M | $145.7M | $129.2M | $134.0M | $477.0M | $497.1M | $121.6M | ||||||||
| Proceeds From Issuance Of Common Stock | $18.3M | $29.8M | $75.1M | $162.2M | $363.1M | $306.3M | $58.9M | $57.8M | $50.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $64.0K | $11.0K | -$208.0K | -$637.0K | $883.0K | $507.0K | $6.5M | $4.0M | $165.6M | $2.5M | $2.9M | $958.0K | $612.0K | $0.00 | |||||||||||||
| Investing Cash Flow * | $2.3M | $1.3M | $36.8M | $10.9M | -$4.3M | $63.8M | $34.1M | -$40.3M | -$44.9M | $22.7M | -$328.0K | -$57.0K | -$435.0K | -$423.0K | |||||||||||||
| Operating Cash Flow * | -$8.9M | -$9.5M | -$24.9M | -$43.9M | -$41.9M | -$32.9M | -$49.0M | -$61.7M | -$50.6M | -$32.4M | -$19.7M | -$15.7M | -$8.0M | -$4.1M | -$1.0M | ||||||||||||
| Share Based Compensation | $2.5M | $3.4M | $7.9M | $10.9M | $11.5M | $12.0M | $17.9M | $7.7M | $8.0M | $5.4M | $2.6M | $3.0M | $1.8M | $778.0K | $239.0K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.6M | $222.0K | -$906.0K | $405.0K | $2.7M | -$10.8M | $346.0K | $1.8M | -$274.0K | $1.4M | -$112.0K | $1.6M | -$157.0K | $40.0K | $125.0K | ||||||||||||
| Increase Decrease In Accounts Payable | $624.0K | -$2.4M | $840.0K | $4.4M | $1.2M | $8.8M | -$6.1M | -$7.3M | -$2.3M | $3.6M | -$166.0K | $2.2M | $1.3M | $198.0K | $150.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $109.0K | $224.0K | $1.0M | $786.0K | $2.9M | $2.1M | $904.0K | $938.0K | $834.0K | $328.0K | $57.0K | $435.0K | $423.0K | ||||||||||||||
| Increase Decrease In Employee Related Liabilities | -$3.1M | -$1.6M | -$3.9M | -$3.0M | -$4.0M | -$6.5M | -$6.8M | -$3.6M | -$2.3M | -$1.9M | -$1.1M | -$1.3M | |||||||||||||||
| Increase Decrease In Clinical Liabilities | -$5.5M | -$2.3M | -$3.2M | $13.6M | $4.3M | $707.0K | -$868.0K | -$2.0M | -$2.0M | -$1.5M | -$293.0K | -$1.0M | |||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | |||||||||||||||||||||||||||
| Increase Decrease In Accounts Receivable | -$145.0K | $5.2M | -$601.0K | $5.6M | -$3.3M | -$5.1M | $9.4M | -$4.2M | $8.4M | -$151.0K | |||||||||||||||||
| Increase Decrease In Other Accrued Liabilities | $5.7M | $2.0M | -$3.5M | -$3.2M | $12.4M | $2.6M | $1.1M | -$852.0K | -$531.0K | $272.0K | |||||||||||||||||
| Increase Decrease In Inventories | $3.8M | $363.0K | -$2.5M | $8.1M | $724.0K | $9.9M | -$7.6M | $9.5M | -$699.0K | $2.7M | |||||||||||||||||
| Depreciation Depletion And Amortization | $551.0K | $689.0K | $718.0K | $721.0K | $739.0K | $621.0K | $467.0K | $381.0K | $329.0K | ||||||||||||||||||
| Proceeds From Stock Options Exercised | $504.0K | $6.5M | $4.2M | $1.9M | $2.5M | $2.9M | $958.0K | $12.0K | $0.00 | ||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | -$51.0K | $194.0K | $64.0K | $13.0K | $318.0K | $11.0K | -$308.0K | -$385.0K | -$208.0K | -$221.0K | -$457.0K | -$637.0K | -$52.0K | $4.2M | $883.0K | $524.0K | $805.0K | $504.0K | |||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $25.2M | $39.2M | $51.0M | $50.0M | $40.5M | $95.7M | $164.0M | $25.4M | |||||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $22.9M | $37.9M | $13.9M | $38.0M | $44.1M | $28.9M | $127.8M | ||||||||||||||||||||
| Proceeds From Issuance Of Common Stock |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.09 | -$0.80 | -$1.67 | -$2.24 | -$2.50 | -$2.50 | -$2.44 | -$3.65 | -$4.56 | -$2.95 | -$2.87 | -$3.42 | -$1.91 | -$1.96 | -$0.19 | -$0.31 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 98.5M | 90.8M | 81.8M | 73.2M | 54.0M | 37.9M | 33.1M | 26.6M | 16.2M | 12.2M | 6.0M | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 166.7M | 152.4M | 138.1M | 108.9M | 98.5K | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 166.7M | 152.4M | 138.1M | 108.9M | 98.5K | ||||||||||||
| Earnings Per Share Basic | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.10 | -$0.02 | $0.01 | -$0.03 | -$0.06 | -$0.02 | -$0.17 | -$0.35 | -$0.27 | -$0.38 | -$0.55 | -$0.63 | -$0.51 | -$0.62 | -$0.58 | -$0.68 | -$0.64 | -$0.61 | -$0.57 | -$0.65 | -$0.42 | -$0.63 | -$0.80 | -$0.63 | -$0.49 | -$0.54 | -$0.81 | -$1.09 | -$0.77 | -$0.80 | -$1.00 | -$1.22 | -$1.24 | -$1.17 | -$0.92 | -$0.87 | -$0.63 | -$0.74 | -$0.70 | -$0.71 | -$0.66 | -$0.78 | -$0.74 | -$0.75 | -$0.84 | -$1.01 | -$0.85 | -$0.51 | -$0.45 | -$0.46 | -$0.85 | -$0.02 | -$0.02 | -$0.05 | -$0.04 | -$0.04 | -$0.09 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 102.1M | 101.9M | 98.5M | 91.4M | 90.8M | 90.8M | 90.4M | 79.9M | 79.5M | 78.4M | 77.8M | 72.0M | 64.7M | 54.2M | 53.8M | 50.5M | 39.1M | 37.0M | 36.2M | 35.8M | 31.0M | 29.4M | 29.0M | 24.3M | 23.7M | 15.4M | 15.3M | 15.3M | 274.5M | 200.1K | 200.0M | ||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 170.3M | 154.0M | 153.5M | 152.8M | 152.3M | 151.2M | 145.0M | 119.7M | 119.2M | 111.7M | 102.4M | 102.1M | 101.9M | 98.5M | |||||||||||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 170.3M | 154.0M | 196.9M | 152.8M | 152.3M | 151.2M | 145.0M | 119.7M | 119.2M | 111.7M | 102.4M | 102.1M | 101.9M | 98.5M | |||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.10 | $-0.02 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.17 | $-0.35 | $-0.27 | $-0.38 | $-0.55 | $-0.63 | $-0.51 | $-0.62 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.3M | $13.0M | $32.9M | $43.0M | $46.9M | $50.2M | $51.4M | $33.4M | $30.5M | $26.0M | $14.4M | $8.1M | $10.9M | $5.6M | |||
| Additional Paid In Capital | $1.95B | $1.88B | $1.87B | $1.81B | $1.69B | $1.63B | $1.57B | $1.33B | $914.0M | $564.3M | $530.6M | $378.0M | $307.6M | $235.3M | $174.0M | $149.3M | |
| Costs And Expenses | $116.1M | $117.2M | $172.6M | $227.5M | $304.2M | $316.8M | $356.7M | $261.4M | $225.3M | ||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $853.0K | $637.0K | $904.0K | $1.4M | $2.1M | $2.3M | $2.1M | $1.2M | $989.0K | $771.0K | $257.0K | $91.0K | $34.0K | $22.0K | $15.0K | $30.0K | |
| Depreciation And Amortization | $1.1M | $734.0K | $578.0K | $333.0K | $197.0K | $179.0K | $227.0K | $356.0K | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $6.8M | $22.2M | $18.3M | $11.5M | $6.7M | $9.5M | $3.1M | $2.8M | $47.0K | ||||||||
| Interest Paid Net | $6.5M | $4.9M | $3.1M | $2.3M | $1.2M | $1.2M | $2.8M | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.9M | $2.8M | $2.5M | $2.7M | $4.6M | $3.4M | $6.7M | $13.9M | $7.9M | $11.2M | $10.4M | $10.9M | $11.2M | $11.2M | $11.5M | $11.1M | $11.1M | $12.0M | $9.7M | $12.7M | $17.9M | $8.1M | $7.8M | $7.7M | |||||||||||||||||||||
| Additional Paid In Capital | $1.94B | $1.89B | $1.89B | $1.88B | $1.88B | $1.87B | $1.87B | $1.83B | $1.82B | $1.80B | $1.71B | $1.70B | $1.68B | $1.67B | $1.64B | $1.61B | $1.59B | $1.58B | $1.39B | $1.38B | $1.35B | $1.32B | $1.30B | $925.7M | $760.5M | $747.6M | $738.0M | $555.5M | $547.0M | $538.6M | $522.9M | $518.4M | $383.5M | $375.3M | $373.0M | $311.6M | $242.6M | $237.4M | $234.9M | $230.3M | $178.8M | $174.8M | $173.2M | $151.2M | |
| Costs And Expenses | $30.4M | $29.0M | $27.3M | $27.8M | $32.0M | $31.0M | $38.2M | $54.0M | $45.8M | $53.7M | $77.1M | $86.4M | $74.9M | $82.9M | $72.1M | $78.3M | $78.4M | $78.1M | $77.5M | $88.4M | $96.3M | $61.6M | $56.1M | ||||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $587.0K | $175.0K | $704.0K | $772.0K | $1.5M | $1.5M | $1.2M | $648.0K | |||||||||||||||||||||||||||||||||||||
| Depreciation And Amortization | $329.0K | $238.0K | $152.0K | $114.0K | $70.0K | $51.0K | $48.0K | ||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $524.0K | $805.0K | $504.0K | $4.0M | $9.7M | $6.5M | $5.1M | $6.4M | $4.2M | ||||||||||||||||||||||||||||||||||||
| Interest Paid Net | $636.0K | $649.0K | $500.0K | $1.0M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.